Chronic myeloid leukemia (CML) is a clonal myeloproliferative expansion of transformed,
primitive hematopoietic progenitor cells. It involves myeloid, monocytic, erythroid, …

The previous edition of the consensus guidelines of the International Workshop on Chronic
Lymphocytic Leukemia (iwCLL), published in 2008, has found broad acceptance by …

… Growth rates of the birds are rapid so they attain slaughter weight in around 40 days. … This
approach has so far not been successful in the control of campylobacters. Commensal gut …

Background The cause of chronic myeloid leukemia (CML) is a constitutively active BCR-ABL
tyrosine kinase. Imatinib inhibits this kinase, and in a short-term study was superior to …

Background Imatinib, a selective inhibitor of the BCR-ABL tyrosine kinase, produces high
response rates in patients with chronic-phase chronic myeloid leukemia (CML) who have had …

… peaks (see text) appeared in the NH-CJH region so suppression10 was unnecessary. N = …
If so, they would provide interesting starting materials for new classes of compounds, reagents…

High-quality and complete reference genome assemblies are fundamental for the application
of genomics to biology, disease, and biodiversity conservation. However, such assemblies …

… Although this report will focus on those changes recommended by the NCI-sponsored CLL
Working Group, it will include sufficient details from the original guidelines so that the reader …

… SO is grateful for support from the DOE and an NSF CAREER award. Author Contributions
EVS and DVT contributed equally to this work. EVS and DVT carried out syntheses of …

… The RH panel is designed to retain small segments of the human genome in different
combinations so that the map location of new markers is implicated by their concordant occurrence …